Every Form 4 that Brunswick Corporation (BC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BC filings page.
BRUNSWICK CORP (BC) reported that officer Aine Denari, EVP, President Navico Group and CTO, had 301 shares of common stock disposed of on 2026-08-19 in a transaction classified as payment of exercise price or tax liability by delivering or withholding securities at $81.61 per share. Following this transaction, Denari beneficially holds 37,393 shares of Brunswick common stock, which include 214 shares acquired through dividend reinvestment through June 2026.
BRUNSWICK CORP (BC) reported an insider transaction by Brenna Preisser, E.V.P. & President Boat Group. On 2026-08-19, 301 shares of common stock were delivered or withheld at $81.61 per share for payment of exercise price or tax liability, leaving 68,858 shares beneficially owned, including 207 acquired via dividend reinvestment through June 2026.
Brunswick Corp director Lauren Patricia Flaherty reported a grant of 562 deferred shares of common stock on July 31, 2026 at $79 per share. The deferred shares are held in a director deferred account and will be distributed in predetermined installments after she ceases serving as director.
Following this award, her direct beneficial holdings total 18,247 shares, including 91 shares acquired through dividend reinvestments through June 2026.
Brunswick Corp director Reginald Fils-Aime reported a compensation-related acquisition of 601 shares of Common Stock on 2026-07-31, coded as a grant, award, or other acquisition at 79.0000 per share. Following this grant, his directly owned Brunswick common stock holdings total 12,052 shares.
Brunswick Corp director Roger Wood received a grant of 585 deferred common shares on July 31, 2026 at $79 per share. The shares were credited to his director deferred account and will be distributed in predetermined installments after he leaves the board. Following this award, he beneficially holds 68,610 shares, including 352 shares acquired through dividend reinvestments through June 2026.
BRUNSWICK CORP director David C. Everitt received a grant of 740 deferred shares of common stock on 2026-07-31 at $79 per share. These deferred shares are deposited in his director deferred account and will be distributed in predetermined installments after he ceases being a director, bringing his direct holdings to 39,908 shares, including 203 shares acquired through dividend reinvestments through June 2026.
Brunswick Corp director David V. Singer reported a grant, award, or other acquisition of 1,046 shares of common stock on 2026-07-31 at $79.00 per share. Following this award, he directly holds 37,546 shares, including 437 deferred shares credited to a deferred account that will be distributed in predetermined installments after he ceases serving as a director. Beneficial holdings also include 140 shares acquired through dividend reinvestment through June 2026, and an additional 19,789 shares are reported as indirectly owned via the Barbara B Singer 2014 Irrevocable Trust.
Brunswick Corp director MaryAnn Wright reported a grant of 581 shares of common stock on July 31, 2026, at $79 per share. These deferred shares were deposited into her director deferred account and will be distributed in predetermined installments after she leaves the board. Following this award, she beneficially holds 11,764 shares, including 58 shares acquired through dividend reinvestment through June 2026.
Brunswick Corp director Joseph W. McClanathan received a grant of 562 shares of common stock on July 31, 2026 at a reference price of $79.00 per share. After this award, he beneficially owns 28,238 shares, including 114 shares acquired through dividend reinvestment through June 2026.
WHISLER J STEVEN reported acquisition or exercise transactions in this Form 4 filing.
BRUNSWICK CORP director J Steven Whisler received a grant of 1,026 deferred common shares on July 31, 2026 at $79.00 per share, credited to his director deferred account. These deferred shares will be automatically distributed in predetermined installments after he ceases being a director. Following this award he beneficially owns 100,003 common shares directly, including 481 from dividend reinvestments through June 2026, and 1,000 shares indirectly through a Family Trust.
Brunswick Corp director Nancy E. Cooper reported two Common Stock transactions. On July 31, 2026, she acquired 589 shares at $79.00 per share through a grant or award. On August 3, 2026, she sold 206 shares at $78.45 per share in an open market or private transaction. These trades are reported as made under a Rule 10b5-1 trading plan.
Brunswick Corp Chief Executive Officer David M. Foulkes reported an open-market sale of 25,853 shares of common stock. The shares were sold on May 26, 2026 at a weighted average price of $83.12 per share, with individual trade prices ranging from $82.60 to $83.53.
After the sale, Foulkes directly holds 267,528 Brunswick shares. He also has an estimated 7,163 additional shares held indirectly through a savings plan trustee, where the exact share count varies with Brunswick’s stock price. Beneficial holdings include 889 shares acquired through dividend reinvestment in March 2026.
MCCLANATHAN JOSEPH W reported acquisition or exercise transactions in this Form 4 filing.
BRUNSWICK CORP director Joseph W. McClanathan received a stock award of 527 shares of common stock. The shares were granted at a reference price of $79.45 per share and are held directly.
After this grant, his direct holdings total 27,562 Brunswick shares, indicating this was a relatively small, routine compensation-related award.
BRUNSWICK CORP director MaryAnn Wright received a grant of 547 shares of Common Stock, valued at $79.45 per share, as of April 30, 2026. These are deferred shares deposited into her director deferred account and will be distributed in preset installments after she ceases being a director. Following this award, her beneficial holdings total 11,125 shares, including 67 shares acquired through dividend reinvestment through March 2026.
BRUNSWICK CORP director David V. Singer reported a compensation grant of common stock and updated holdings. He received 989 shares of common stock as a grant or award at $79.45 per share, bringing his direct holdings to 36,360 shares. He also reports 19,789 shares held indirectly through the Barbara B Singer 2014 Irrevocable Trust. Footnotes note that 415 of the reported shares are deferred shares to be distributed after he ceases being a director, and 168 shares were acquired through dividend reinvestment.
Brunswick Corp director David C. Everitt received a grant of 704 shares of common stock, valued at $79.45 per share. These are deferred shares deposited into his director deferred account and will be automatically distributed in predetermined installments after he ceases serving as a director. Following this award, his beneficial holdings total 38,965 shares, including 241 shares acquired through dividend reinvestments through March 2026.
BRUNSWICK CORP director J. Steven Whisler received a compensation-related stock award rather than making an open-market trade. He was granted 970 shares of common stock at $79.45 per share, credited as deferred shares to his director deferred account and scheduled to be distributed in installments after he leaves the board.
Following this grant, Whisler’s direct beneficial holdings total 98,496 shares, which include 578 shares acquired through dividend reinvestments through March 2026. In addition, 1,000 shares are reported as held indirectly by a family trust associated with the director.
Brunswick Corp director Roger Wood received a grant of 551 shares of Common Stock on April 30, 2026, as a compensation award rather than an open‑market purchase. The shares were valued at $79.45 each and are credited as deferred shares in his director deferred account.
These deferred shares will be automatically distributed in predetermined installments after he ceases serving as a director. Following this grant, Wood beneficially holds 67,673 shares, including 424 shares acquired through dividend reinvestments through March 2026.
Brunswick Corp director Nancy E. Cooper reported a small mix of equity award and share sale. On April 30, she acquired 555 shares of Brunswick common stock as a grant/award acquisition at $79.45 per share. On May 1, she completed an open-market sale of 194 shares at a weighted average price of $79.36, with individual trade prices ranging from $79.35 to $79.40. After these transactions, she directly holds 27,801 shares of Brunswick common stock, indicating that the sale represents only a small portion of her overall position.
BRUNSWICK CORP director Lauren Patricia Flaherty received a stock-based compensation award. She acquired 527 shares of Brunswick common stock on April 30, 2026 as a grant at $79.45 per share. These shares were deposited into her director deferred account and will be distributed in predetermined installments after she ceases serving on the board.
After this grant, her beneficial holdings total 17,594 shares of Brunswick common stock, which includes 108 shares accumulated through dividend reinvestments through March 2026. The filing reflects routine director compensation rather than an open-market purchase or sale.
Brunswick Corp director Reginald Fils-Aimé received a stock award of 566 shares of Common Stock on April 30, 2026. The award is reported at a price of $79.45 per share and is categorized as a grant or other acquisition. After this award, he directly holds 11,451 Brunswick shares.
Brunswick Corp director Nancy E. Cooper reported an open-market sale of common stock. She sold 192 shares at a price of $87.64 per share. After this transaction, she directly owns 27,440 shares of Brunswick common stock.
Brunswick Corporation executive Ryan M. Gwillim, the EVP, CFO and CSO, reported an open‑market sale of common stock. On February 17, 2026, he sold 12,785 shares at a weighted average price of $87.23 per share, in multiple transactions between $86.58 and $88.09.
After this sale, he directly owned 32,255 Brunswick shares. The filing also notes an estimated 8,669 shares held indirectly through a savings plan trustee as of February 17, 2026, where the deemed share count can change with the stock price.
Brunswick Corporation executive vice president, CFO and CSO Ryan M. Gwillim was granted 14,510 shares of Brunswick common stock on February 12, 2026 at $86.17 per share as an acquisition award. On February 13, 2026, shares were disposed of in several tax-withholding transactions at $87.04 per share, reducing his directly held stake from 52,190 to 45,040 shares. He also has 8,669 shares held indirectly through a savings plan trustee, with beneficial holdings including 454 dividend reinvestment shares through December 2025.
Brunswick Corporation executive Christopher F. Dekker, EVP, General Counsel & Secretary, reported equity transactions in company common stock. On February 12, 2026, he acquired 6,960 shares at $86.17 per share as a grant or other acquisition, bringing his direct holdings to 46,400 shares.
On February 13, 2026, he had three tax-withholding dispositions (code F) of 2,029, 742, and 1,441 shares at $87.04 per share to cover tax liabilities, leaving 42,188 shares owned directly. He also had 3,574 shares held indirectly by a savings plan trustee, an amount disclosed as an estimate as of February 13, 2026.
Brunswick Corporation executive Aine Denari reported an equity award and related tax withholding in company stock. On February 12, 2026, Denari acquired 7,540 shares of Brunswick common stock at $86.17 per share as a grant or other acquisition.
On February 13, 2026, three transactions coded as tax-withholding dispositions reduced the position by 2,142, 1,044 and 1,555 shares at $87.04 per share. After these transactions, Denari directly owned 37,480 shares of Brunswick common stock, including shares accumulated through dividend reinvestment through December 2025.
Brunswick Corporation senior vice president and controller Randall S. Altman reported several stock transactions in company shares. On February 12, 2026, he acquired 4,930 shares of common stock at $86.17 per share as a grant or other acquisition, bringing his direct holdings to 31,918 shares.
On February 13, 2026, Altman had three Form F transactions classified as tax-withholding dispositions, disposing of 776, 277 and 677 shares at $87.04 per share, leaving 30,188 directly held shares. He also beneficially owned 5,070 shares indirectly through a savings plan trustee as of February 13, 2026, and his holdings include 305 shares from dividend reinvestment through December 2025.
Brunswick Corporation executive John G. Buelow reported multiple stock transactions. On February 12, 2026, he acquired 7,540 shares of Brunswick common stock at $86.17 per share as an equity award. On February 13, 2026, he had three tax-withholding dispositions (code F) of 2,046, 832 and 1,566 shares at $87.04 per share related to that compensation. After these transactions he directly owned 26,779 shares, which include 533 shares acquired through dividend reinvestment through December 2025.
FOULKES DAVID M reported multiple insider transaction types in a Form 4 filing for BC. The filing lists transactions totaling 101,117 shares at a weighted average price of $86.51 per share. Following the reported transactions, holdings were 292,492 shares.
Brunswick Corporation executive Brenna Preisser reported equity compensation activity and related tax withholding in company stock. On February 12, 2026, she acquired 7,540 shares of common stock at $86.17 per share in a grant or award transaction. On February 13, 2026, shares totaling 4,510 were disposed of at $87.04 per share in tax-withholding transactions to cover obligations tied to equity compensation. Following these transactions, she directly beneficially owned 68,952 shares of Brunswick common stock. Beneficial holdings also include 245 shares acquired through dividend reinvestment through December 2025.
Brunswick Corporation executive Jill Wrobel reported equity compensation activity in company common stock. On February 12, 2026, she acquired 6,380 shares of Brunswick common stock at $86.17 per share in a grant or other award, bringing her holdings to 28,278 shares.
On February 13, 2026, shares were disposed of through tax-withholding transactions coded "F": 1,877 shares, 871 shares, and 1,271 shares, each at $87.04 per share. After these withholding dispositions, she directly owned 24,259 common shares. Her beneficial holdings also include 448 shares acquired via dividend reinvestment through December 2025.
Brunswick Corporation executive Christopher F. Dekker, EVP, General Counsel & Secretary, reported two transactions in Brunswick common stock. On February 6, 2026, he sold 4,981 shares at a weighted average price of $87.38 per share, in trades ranging from $86.63 to $88.29, leaving 39,740 directly held shares.
On February 9, 2026, he made a gift of 300 shares at $0, after which his direct holdings were 39,440 shares. Footnotes state his beneficial holdings include 355 shares from dividend reinvestment through December 2025 and an estimated 3,569 shares held indirectly through a savings plan trustee as of February 9, 2026.
Brunswick Corporation’s chief executive officer, David M. Foulkes, reported an open-market sale of company stock. On February 5, 2026, he sold 38,266 shares of Brunswick common stock at a weighted average price of $86.56, with individual trade prices ranging from $85.55 to $87.64.
After this transaction, he beneficially owns 271,169 Brunswick shares directly and an additional estimated 7,121 shares indirectly through a savings plan trustee. His beneficial holdings include 4,647 shares that were acquired through dividend reinvestment through December 2025.
Brunswick Corporation director J. Steven Whisler reported receiving 961 shares of Brunswick common stock on January 30, 2026, at a price of $80.22 per share. These are deferred shares credited to his director deferred account and will be paid out in predetermined installments after he leaves the board.
Following this transaction, Whisler beneficially owns 96,948 common shares directly, which include 517 shares from dividend reinvestments in December 2025, and an additional 1,000 shares indirectly held by a family trust.
Brunswick Corporation director David V. Singer reported acquiring 981 shares of the company’s common stock on January 30, 2026 at $80.22 per share. Following this transaction, he directly holds 35,203 shares, including 412 deferred shares that will be paid out after he leaves the board and 150 shares received through dividend reinvestment in December 2025.
In addition to his direct holdings, 19,789 shares are held indirectly through the Barbara B Singer 2014 Irrevocable Trust, reflecting additional beneficial ownership reported in this filing.
Brunswick Corporation director Joseph W. McClanathan reported an acquisition of company stock. On 01/30/2026, he acquired 934 shares of Brunswick common stock at $80.22 per share. After this transaction, he beneficially owned 26,898 shares held directly.
Footnotes explain that 412 of these shares are deferred into a director deferred account, to be distributed in installments after he leaves the board. His beneficial holdings also include 122 shares received through dividend reinvestment in December 2025.
Brunswick Corporation director Lauren Patricia Flaherty reported acquiring 522 shares of Brunswick common stock on January 30, 2026 at $80.22 per share. These are deferred shares credited to the director’s deferred account and are scheduled to be paid out in predetermined installments after she leaves the board.
Following this transaction, Flaherty beneficially owns 16,959 Brunswick shares, held directly. This total includes 94 shares that were added through dividend reinvestments in December 2025.
Brunswick Corporation director Roger Wood reported an acquisition of company stock through a Form 4 filing. On January 30, 2026, he acquired 545 shares of Brunswick common stock at a price of $80.22 per share, recorded as an acquisition of non-derivative securities.
Following this transaction, Wood beneficially owned 66,698 shares of Brunswick common stock, held directly. The filing notes that his beneficial holdings include 380 shares that were added earlier through dividend reinvestment in December 2025, and that the new shares are deferred and will be distributed after he ceases serving as a director.
Brunswick Corporation director David C. Everitt reported an acquisition of 697 shares of Brunswick common stock on January 30, 2026, at $80.22 per share. The shares were credited as deferred stock into his director deferred account and will be paid out in set installments after he leaves the board.
Following this transaction, Everitt directly beneficially owned 38,020 Brunswick shares, which include 215 shares acquired through dividend reinvestments in December 2025.
Brunswick Corporation director MaryAnn Wright received 541 deferred common shares at $80.22 each on January 30, 2026, bringing her direct beneficial ownership to 10,511 shares. These deferred shares are held in a director deferred account and will be distributed in predetermined installments after she leaves the board.
The filing also notes that her beneficial holdings include 57 shares acquired through dividend reinvestment in December 2025, reflecting ongoing accumulation of Brunswick stock via the company’s dividend reinvestment mechanism.
Brunswick Corporation director Nancy E. Cooper reported acquiring 549 shares of common stock on January 30, 2026 at a price of $80.22 per share. Following this transaction, she beneficially owned 27,632 shares held directly. This was reported as a routine insider Form 4 filing under SEC rules.
Brunswick Corporation director Reginald Fils-Aime reported acquiring additional common stock. On 01/30/2026, he acquired 561 shares of Brunswick common stock at a price of $80.22 per share. Following this transaction, he directly beneficially owned 10,885 shares of Brunswick common stock.
Brunswick Corporation (BC) reported an insider transaction by a director on 10/31/2025. The filing shows an acquisition of 1,166 shares at $66.11, identified as deferred shares that will be distributed in installments after the individual ceases serving as a director.
Following the transaction, the director beneficially owns 95,470 shares directly and 1,000 shares indirectly through a family trust. Footnotes add that direct holdings include 579 shares acquired via dividend reinvestments in September 2025.
Brunswick Corporation (BC) reported an insider transaction by a director. On 10/31/2025, the director acquired 657 shares of common stock at $66.11 (code A). Following this, the director beneficially owns 9,913 shares, held directly.
Footnotes state the acquired shares are deferred shares deposited into the director’s deferred account, to be distributed in predetermined installments after the director ceases serving on the board. Beneficial holdings include 61 shares acquired via dividend reinvestment in September 2025.
Brunswick Corporation (BC) director Reginald Fils-Aime reported acquiring 681 shares of common stock at $66.11 on 10/31/2025.
After this transaction, his directly held position totaled 10,324 shares. No derivative securities were reported.
Brunswick Corporation (BC) reported an insider transaction by director Lauren Patricia Flaherty. On 10/31/2025, 633 shares of common stock were acquired at $66.11, recorded as deferred shares deposited in a director deferred account. Following the transaction, beneficial ownership stood at 16,343 shares. Beneficial holdings include 103 shares acquired through dividend reinvestments in September 2025.
Brunswick Corporation (BC) reported insider activity by a director on Form 4. The filing shows a purchase of 667 shares of common stock on 10/31/2025 at $63.11 per share, followed by a sale of 233 shares on 11/03/2025 at $64.12 per share.
Following these transactions, the director beneficially owned 27,316 shares after the purchase and 27,083 shares after the sale, held in direct ownership.
Brunswick Corporation (BC) director reported an insider acquisition. On 10/31/2025, the director acquired 846 shares of common stock at $66.11, recorded as deferred shares credited to the director’s deferred account. Following the transaction, beneficial ownership stands at 37,108 shares, held directly.
The deferred shares will be automatically distributed in predetermined installments after the individual ceases serving as a director. Beneficial holdings include 238 shares acquired through dividend reinvestments in September 2025.
Brunswick Corp (BC) reported an insider transaction on Form 4. Director Joseph W. McClanathan acquired 1,132 shares of common stock on 10/31/2025 at $66.11 per share (Transaction Code A). Following the transaction, he beneficially owns 25,842 shares. The filing notes that 499 of these shares are deferred and will be distributed in installments after he ceases being a director, and that holdings include 135 shares acquired via dividend reinvestment in September 2025.
Brunswick Corporation (BC) reported an insider transaction by a director. On 10/31/2025, the director acquired 1,189 shares of common stock at $66.11 per share. Following the transaction, the director beneficially owns 34,072 shares directly and 19,789 shares indirectly via the Barbara B Singer 2014 Irrevocable Trust.
The filing notes that 499 shares are deferred shares in the director’s deferred account to be distributed in predetermined installments after board service ends, and holdings include 166 shares acquired through dividend reinvestment in September 2025.